Nazli A. Guner

Nazli A. Guner is a pharmaceutical industry professional focused on corporate business development, with an emphasis on the commercial evaluation of acquisition opportunities drawing on her experience inside the industry.

Her career began fifteen years ago at AstraZeneca and continued across sales, marketing and medical operations at global pharmaceutical companies including AstraZeneca and GSK, spanning CNS, respiratory, dermatology and, briefly, ophthalmology. Earlier in her career, she served in the Office of the COO at the Royal Bank of Scotland, supporting executive-level operations for the Eastern European region.

Since 2022 her work formally focused on tracked deals across biotechnology and pharma, and until 2023 she contributed to international projects on a part-time basis. She holds two Bachelor of Science degrees, including Biological Sciences from Middle East Technical University, and studied at Claremont Colleges and the University of California, Los Angeles on scholarships.

Here she shares occasional thoughts on industry trends and welcomes direct conversations with leaders and professionals across the industry. Contact Nazli.